Sarah Fletcher, MD
Family Medicine · Sterling, VANPI 1184610578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $450 and has fallen 57.1% since, to $193 in 2025.
Across 82 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$198
- AbbVie$137
- AstraZeneca$113
- Lilly USA, LLC$102
- Pfizer$84
- GSK$78
- plus $766 from 26 others
What the payments were for
- Food & beverage$1,478100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $198 |
| AbbVie(2 entities) | 7 | $137 |
| AstraZeneca | 6 | $113 |
| Lilly USA, LLC | 6 | $102 |
| Pfizer | 5 | $84 |
| GSK | 4 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $78 |
| IBSA Pharma Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Cranial Technologies, Inc | 4 | $57 |
| Covidien LP | 1 | $54 |
| Johnson & Johnson | 2 | $40 |
| Acella Pharmaceuticals, LLC | 2 | $37 |
| QOL Medical, LLC | 1 | $27 |
| UCB, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Qorumpartners | 2 | $25 |
| Exact Sciences | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Abbott | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Medtronic | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Vyera Pharmaceuticals, LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Merck | 1 | $13 |
How this compares
$1,478 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyremSodium Oxybate | 12 | $333,310 |
| Liothyronine Sodium | 18 | $868 |
| Levothyroxine Sodium | 59 | $601 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $415 |
| Diclofenac Sodium | 13 | $377 |
| Escitalopram Oxalate | 18 | $337 |
| Doxycycline Hyclate | 13 | $246 |
| Metoprolol Succinate | 19 | $149 |
| Simvastatin | 11 | $133 |
| Atorvastatin Calcium | 18 | $130 |
| Sumatriptan Succinate | 15 | $127 |
| Losartan Potassium | 14 | $126 |
| Pregabalin | 12 | $101 |
| Clonazepam | 14 | $91 |
| Lisinopril | 27 | $71 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Sterling
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.